SCHEMBL25286809

SCHEMBL25286809

O=C(O)NCC1CCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3636695 0.72 TDP1 (0.52)
SCHEMBL14721746 0.71 EPHX1 (0.44)
SCHEMBL1695048 0.71 CYP2D6 (0.40)
SCHEMBL21542173 0.71 CYP2D6 (0.53)
SCHEMBL20520880 0.71 CYP2D6 (0.37)
SCHEMBL24636837 0.71 FUCA1 (0.35)
SCHEMBL4396572 0.70 CYP2D6 (0.63)
SCHEMBL217411 0.70
SCHEMBL4396576 0.70 CYP2D6 (0.63)
SCHEMBL8644956 0.70 CYP2D6 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11897851-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2024-02-13 US disclosed
WO-2024026338-A1 N-HETEROCYLIC GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE CARMOT THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
US-20230192633-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-06-22 US disclosed